Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-19

FDA Approved: ETHOSUXIMIDE — Original Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approves Strides Pharma Science Limited's original ANDA for ethosuximide, a generic treatment for absence seizures in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ethosuximide (ethosuximide)

Snippet

ORIG AP for ETHOSUXIMIDE (ETHOSUXIMIDE)